Alastair Garfield

RYTM

Alastair Garfield serves as officer: Chief Scientific Officer at Rhythm Pharmaceuticals, Inc. (RYTM). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$998.2K

Net Position

Net Seller

$998.2K

Companies Traded

RYTM

Active Period

Jul 2025 – Aug 2026

2 total trades

Most Recent

Sell RYTM

Aug 17, 2026 · $912.7K

Alastair Garfield's Insider Trading at Rhythm Pharmaceuticals, Inc. (RYTM)

Buys

0 · $0.00

Sells

2 · $998.2K

Total Shares Bought

Total Shares Sold

9,082

RYTM Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 17, 2026	Sell	7,763	$117.57	$912.7K	8,051
Jul 3, 2025	Sell	1,319	$64.81	$85.5K	3,132

Related Insiders

David P Meeker

director, officer: President and CEO

RYTMSell · Sep 14, 2026

Hunter C Smith

officer: Chief Financial Officer

RYTMSell · Sep 1, 2026

Joseph Shulman

officer: Chief Technical Officer

RYTMSell · Aug 17, 2026

Jennifer Kayden Lee

officer: EVP, Head of North America

RYTMSell · Aug 14, 2026

Yann Mazabraud

officer: EVP, Head of International

RYTMSell · Aug 14, 2026

TETRAULT LYNN A.

director

RYTMSell · Jun 24, 2026

Christopher Paul German

officer: Corporate Controller & CAO

RYTMSell · May 19, 2026

Pamela J. Cramer

Chief Human Resources Officer

RYTMSell · Dec 15, 2025

Explore More Insider Trading Data

RYTM Insider Trading Activity

View all insider trades at Rhythm Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity